National Research Co. (NASDAQ:NRC) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC grew its stake in National Research Co. (NASDAQ:NRC) by 6.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 404,886 shares of the company’s stock after purchasing an additional 25,002 shares during the period. Renaissance Technologies LLC’s holdings in National Research were worth $7,142,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of NRC. PNC Financial Services Group Inc. lifted its holdings in National Research by 2,250.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company’s stock valued at $27,000 after acquiring an additional 1,463 shares during the period. KLP Kapitalforvaltning AS purchased a new position in shares of National Research during the 4th quarter valued at approximately $50,000. FMR LLC increased its holdings in shares of National Research by 397.3% during the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after purchasing an additional 2,352 shares in the last quarter. Signaturefd LLC boosted its holdings in National Research by 613.3% during the fourth quarter. Signaturefd LLC now owns 4,173 shares of the company’s stock worth $74,000 after buying an additional 3,588 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its position in National Research by 219.3% during the fourth quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company’s stock valued at $88,000 after buying an additional 3,438 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Up 0.1 %

NRC opened at $10.54 on Friday. The company has a fifty day moving average of $14.04 and a two-hundred day moving average of $16.88. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a fifty-two week low of $10.40 and a fifty-two week high of $35.81. The stock has a market capitalization of $241.85 million, a price-to-earnings ratio of 10.04 and a beta of 0.41.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Monday, January 27th. The company reported $0.28 earnings per share for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.55%. National Research’s dividend payout ratio (DPR) is 45.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.